Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year

APTA Results (4,988 Results)

Includes articles, courses, and CPGs. Unlimited access for APTA members.

APTA’s Report on Direct Access Is a Tool for Action

Jul 7, 2025/News

APTA’s latest advocacy resource helps members improve patient access, payment, and consumer awareness of direct access to PT services.

From Near Death To Walking Steady: A COVID-19 Survivor's Journey

Jul 16, 2020/Podcast

Brian de Castro didn't fit the profile of someone likely to find himself in a life-and-death battle with COVID-19. His entire family got the virus and recovered quickly, but the 39-year-old who was in good health, is required two weeks on a ventilator. Physical therapy was key to his recovery.

APTA Programs Earn National Recognition

Jul 16, 2019/News

APTA once again received national honors from the American Society of Association Executives.

55th McMillan Lecture: Meeting Global Responsibilities

Feb 16, 2024/News

Judith Deutsch, PT, PhD, FAPTA, urged the profession to "look outward and move forward."

APTA Releases 2023 Annual Report

Apr 29, 2024/News

Together, we advanced the profession and strengthened the APTA community.

Get to Know APTA Pelvic Health: An Interview With Academy President Darla Cathcart

May 6, 2025/Podcast

A brief introduction from the president of the academy.

Study: Use of PTAs, More Therapy Intensity, Associated With Better SNF Outcomes

Jul 28, 2021/Review

An analysis of SNFs across the country echoes some themes from recent research sponsored by APTA and AOTA.

Study: Pre- and Post-TKR Physical Therapy Lowers Odds of Long-Term Opioid Use

Nov 5, 2021/Review

A large-scale study found that the lowered odds are especially significant for "opioid-experienced" patients.

Numeric Pain Rating Scale (NPRS)

May 4, 2023/Test & Measure

Measures the subjective intensity of pain.

Study: Even Small Amounts of PA Can Reduce CVD Risk Among the Elderly

Dec 4, 2017/Review

This study is notable because of its focus on participants 65 and older, and its 18-year median follow-up duration.